O ~I defcitse against cancer probably ex-H ists to a significant degree. T h e development of clinical cancer may indicate an impaired resistance, one manifestation of which could be an altered antibody response to standard antigens.
No takes yet. Share an insight, caveat, or question.
Leskowitz et al. (1957) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: